Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Breast (Edinburgh, Scotland)
|
November 19, 2024
Treatment of oligometastatic breast cancer: The role of patient selection
Riccardo Ray Colciago, Maria Carmen De Santis, Carlotta Giandini, et al.
Cancers
|
November 11, 2022
Integration between Novel Imaging Technologies and Modern Radiotherapy Techniques: How the Eye Drove the Chisel
Giulio Francolini, Ilaria Morelli, Maria Grazia Carnevale, et al.
Scientific Reports
|
September 3, 2024
Low-pass whole genome sequencing of circulating tumor cells to evaluate chromosomal instability in triple-negative breast cancer
Serena Di Cosimo, Marco Silvestri, Cinzia De Marco, et al.
Discover Oncology
|
August 26, 2025
Real world feasibility of combining pembrolizumab with radiotherapy in early triple negative breast cancer
Riccardo Ray Colciago, Daniele Presti, Carlotta Giandini, et al.
Clinical Breast Cancer
|
February 8, 2026
Event-Free Survival After Stereotactic Body Radiation Therapy for Oligoprogressive Metastatic Breast Cancer
Riccardo Ray Colciago, Carlotta Giandini, Anna Cavallo, et al.
Tumori
|
October 25, 2024
Fat necrosis after accelerated partial breast irradiation or hypofractionated whole breast irradiation: A case-control study
Riccardo Ray Colciago, Eliana La Rocca, Carlotta Giandini, et al.
Cancers
|
January 8, 2025
Recent Advances and Current Challenges in Stereotactic Body Radiotherapy for Ultra-Central Lung Tumors
Viola Salvestrini, Andrea Lastrucci, Marco Banini, et al.
Breast (Edinburgh, Scotland)
|
May 27, 2025
Advancing breast cancer therapy in the era of molecular diagnostics
Maria Grazia Carnevale, Riccardo Ray Colciago, Maria Carmen De Santis, et al.
Journal of Geriatric Oncology
|
December 10, 2022
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy
Giulio Francolini, Giulio Frosini, Vanessa Di Cataldo, et al.
Frontiers in Oncology
|
April 7, 2023
Choline PET/CT in recurrent prostate cancer
Beatrice Detti, Maria Grazia Carnevale, Sara Lucidi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Breast (Edinburgh, Scotland)
|
November 19, 2024
Treatment of oligometastatic breast cancer: The role of patient selection
Riccardo Ray Colciago, Maria Carmen De Santis, Carlotta Giandini, et al.
Cancers
|
November 11, 2022
Integration between Novel Imaging Technologies and Modern Radiotherapy Techniques: How the Eye Drove the Chisel
Giulio Francolini, Ilaria Morelli, Maria Grazia Carnevale, et al.
Scientific Reports
|
September 3, 2024
Low-pass whole genome sequencing of circulating tumor cells to evaluate chromosomal instability in triple-negative breast cancer
Serena Di Cosimo, Marco Silvestri, Cinzia De Marco, et al.
Discover Oncology
|
August 26, 2025
Real world feasibility of combining pembrolizumab with radiotherapy in early triple negative breast cancer
Riccardo Ray Colciago, Daniele Presti, Carlotta Giandini, et al.
Clinical Breast Cancer
|
February 8, 2026
Event-Free Survival After Stereotactic Body Radiation Therapy for Oligoprogressive Metastatic Breast Cancer
Riccardo Ray Colciago, Carlotta Giandini, Anna Cavallo, et al.
Tumori
|
October 25, 2024
Fat necrosis after accelerated partial breast irradiation or hypofractionated whole breast irradiation: A case-control study
Riccardo Ray Colciago, Eliana La Rocca, Carlotta Giandini, et al.
Cancers
|
January 8, 2025
Recent Advances and Current Challenges in Stereotactic Body Radiotherapy for Ultra-Central Lung Tumors
Viola Salvestrini, Andrea Lastrucci, Marco Banini, et al.
Breast (Edinburgh, Scotland)
|
May 27, 2025
Advancing breast cancer therapy in the era of molecular diagnostics
Maria Grazia Carnevale, Riccardo Ray Colciago, Maria Carmen De Santis, et al.
Journal of Geriatric Oncology
|
December 10, 2022
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy
Giulio Francolini, Giulio Frosini, Vanessa Di Cataldo, et al.
Frontiers in Oncology
|
April 7, 2023
Choline PET/CT in recurrent prostate cancer
Beatrice Detti, Maria Grazia Carnevale, Sara Lucidi, et al.
Page
of 2